Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence

Hana Gerber*, Stefan J. Borgwardt, Otto Schmid, Urs Gerhard, Wolfgang Joechle, Anita Riecher-Rössler, Gerhard A. Wiesbeck, Marc Walter

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Background/Aim: Heroin dependence is a chronic relapsing disorder characterized by the compulsion to seek and use heroin. Stress and craving are seen as key factors for heroin use. Moreover, altered hypothalamic-pituitary- adrenal (HPA) axis function has been frequently reported. However, the acute effects of diacetylmorphine (DAM) on HPA axis activity and craving have not been investigated in a controlled study. The present randomized controlled study examined whether DAM administration differs from placebo (saline) administration with regard to HPA axis response and heroin craving. Methods: In a crossover experiment, 28 DAM-maintained heroin-dependent patients were first injected with DAM and then saline, or the converse. Plasma adrenocorticotropic hormone (ACTH) and cortisol in saliva and serum were measured at baseline and 20 and 60 min after both injections. Heroin craving was measured at baseline and 60 min after both injections, by means of the Heroin Craving Questionnaire. Results: Compared to saline, DAM administration induced a significant decrease in plasma ACTH (p < 0.01), serum cortisol (p < 0.0001) and saliva cortisol (p < 0.01), as well as in craving (p < 0.0001), over time. Conclusion: Since acute DAM administration suppresses the stress response, DAM-assisted treatment may be an effective alternative to methadone maintenance in stress-sensitive heroin-dependent patients.

OriginalspracheEnglisch
ZeitschriftEuropean Addiction Research
Jahrgang18
Ausgabenummer3
Seiten (von - bis)116-123
Seitenumfang8
ISSN1022-6877
DOIs
PublikationsstatusVeröffentlicht - 04.2012

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Fingerprint

Untersuchen Sie die Forschungsthemen von „The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren